ARTG 473747Gastrointestinal radio-frequency ablation system catheter
ARTG ID: 473747 · Medtronic Australasia Pty Ltd · Covidien llc · Class IIb · Started December 18, 2024
Good Name: Medtronic Australasia Pty Ltd - Gastrointestinal radio-frequency ablation system catheter
- Risk Class
- Class IIb
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 473747
- Start Date
- December 18, 2024
- Effective Date
- December 18, 2024
- Name
- Covidien llc
- Country
- United States of America
- Address
- 15 Hampshire Street, Mansfield, MA, 02048
Ablation catheters indicated for use in the coagulation of bleeding and non-bleeding sites in the gastrointestinal tract, including but not limited to, Barret’s esophagus and esophageal squamous cell neoplasia defined as moderate grade intra-epithelial neoplasia (MGIN), high grade intra-epithelial neoplasia (HGIN), and/or early squamous cell carcinoma (SCC) of the esophagus limited to the lamina propria (i.e. T1m2).
Access comprehensive regulatory information for Gastrointestinal radio-frequency ablation system catheter in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 473747 and sponsored by Medtronic Australasia Pty Ltd, manufactured by Covidien llc in United States of America. The device registration started on December 18, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.